Has Frank Ocasio, MD received payments from drug or device companies?

Yes. Drug and device makers reported $25,788 in general payments to Frank Ocasio, MD across 179 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Frank Ocasio, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Frank Ocasio, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Frank Ocasio, MD

Anesthesiology · Huntington, NYNPI 1780822593

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $17,888 of the $25,788 with a category attached, or 69.4%. Relievant Medsystems, Inc. accounts for 69.0% of it on its own, with 22 other manufacturers making up the rest. Reporting peaked in 2023 at $12,311 and has fallen 86.9% since, to $1,611 in 2025. Among anesthesiology clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$25,788in general payments, 2019–2025

Across 179 payments — averaging $144.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Relievant Medsystems, Inc.$18K
Boston Scientific$4K
AbbVie$797
Nevro Corp.$583
Si-bone, Inc.$544
Lundbeck LLC$463
plus $2K from 17 others

What the payments were for

Consulting fees$4502%
Speaking & faculty fees$17,88869%
Travel & lodging$8233%
Food & beverage$6,62726%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Relievant Medsystems, Inc.	56	$17,788
Boston Scientific	27	$4,079
AbbVie(2 entities)	39	$797
Nevro Corp.	5	$583
Si-bone, Inc.	5	$544
Lundbeck LLC	10	$463
Nalu Medical, Inc.	4	$299
Medtronic(2 entities)	6	$262
SPR Therapeutics, Inc	4	$238
Painteq LLC	3	$155
Trice Medical, Inc.	1	$138
MML US, Inc.	1	$73
Biohaven Pharmaceuticals, Inc.	3	$68
Abbott	2	$55
Amgen	4	$54
Smith+Nephew	2	$47
Curonix LLC	1	$29
Johnson & Johnson	1	$26
Mimedx Group, Inc.	1	$19
Pacira Pharmaceuticals Incorporated	1	$19
Impel Pharmaceuticals LLC	1	$17
Ferring Pharmaceuticals Inc.	1	$17
Biohaven Pharmaceutical Holding Company Ltd.	1	$17

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Intracept$57,106
Senza Spinal Cord Stimulation System$554
Nalu Neurostimulation System$267
SPRINT PNS System$167
O-ARM-Spine$142
BOTOX$125
VYEPTI$125

How this compares

$25,788 in reported general payments places this provider in the 95th percentile of 4,157 anesthesiology providers in New York.

See all anesthesiology providers in New York →

Medicare billing

Part B allowed, 2024

$349,098

Medicare patients

140

Services billed

4,951

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen	52	$483
Tramadol Hcl	24	$201
Gabapentin	32	$188
Methylprednisolone	15	$157
Oxycodone Hcl	12	$130
Nabumetone	14	$126
Tizanidine Hcl	13	$104

Paid to pharmacies, not to this prescriber.

Other anesthesiology in Huntington

Mark KronenfeldBrooklyn$2.4M
Kiran PatelNew York$832K
Karina GritsenkoBronx$665K
Marc DicksteinNew York$585K
Admir HadzicNew York$510K
Christopher DimeoNew York$449K
Christopher RieglerNew York$429K
William UrmeyNew York$397K
Sudhir DiwanNew York$255K
Daniel KatzNew York$190K

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →